Sartorius AG is currently covered by 28 sell-side analysts. The following list shows banks and securities firms that publish regular research reports on Sartorius´s preference shares.
Shares
Here you will find information on Sartorius preference shares (SRT3) and Sartorius ordinary shares (SRT).
Stock Chart
Stock Chart
Shares Overview
ISIN | Ordinary share: DE0007165607 | Preference share: DE0007165631 |
SE Code | Ordinary share: SRT | Preference share: SRT3 |
Capital stock | 74,880,000 euros |
Number of shares outstanding | Ordinary shares: 34,230,928 | Preference shares: 34,807,268 |
Number of shares | 74,880,000 no-par individual share certificates; thereof Ordinary shares: 37,440,000 | Preference shares: 37,440,000 |
Market Segment | Prime Standard |
Indices | DAX | TecDAX | MSCI Germany Index | CDAX | Prime All-Share-Index | Technology All Share-Index | NISAX20 | STOXX Europe 600 | DAX 50 ESG |
Market places | XETRA | Frankfurt Main | Hanover | Hamburg | Berlin | Munich | Düsseldorf | Stuttgart | Tradegate |
Designated Sponsors | Oddo Seydler Bank AG | M.M. Warburg & Co. |
First trading day | July, 10, 1990; Issue price: Ordinary share DM 710 | Preference share DM 610 |
Post IPO Activities | 04.06.1998: Capital increase by DM 11 million to DM 36 million by preference share at the issue price of DM 630 13.12.1999: Conversion of DM 50 par value shares to individual share certificate with an accounting par value of 1 euro at a ratio of 1:26 (stock split) 13.06.2016: Capital increase by use of retained earnings for carrying out a stock split at a ratio of 1:4 09.02.2024: Placement of 613,497 preference shares (the “Placement Preference Shares”) held in treasury with the exclusion of existing shareholders’ subscription rights (the “Treasury Share Placement”) at a price of 326.00 euros per share |
Paying and exchange agent for Sartorius AG shares | Commerzbank AG (Neue Börsenstraße 1, 60487 Frankfurt am Main, Germany) |
Institution | Analyst |
AlphaValue | Virendra Chauhan |
Bank of America | Charlie Haywood |
Barclays | Charles Pitman-King |
Berenberg | Sam England |
Bernstein | Delphine Le Louet |
Deutsche Bank | Falko Friedrichs |
DZ Bank | Sven Kürten |
EQUI.TS | Thomas J. Schießle |
Exane | Odysseas Manesiotis |
Goldman Sachs | James Quigley |
Guggenheim Securities | Subbu Nambi |
HSBC | Shubhangi Gupta |
Jefferies | James Vane-Tempest |
JP Morgan | Richard Vosser |
Kepler Chevreux | Oliver Reinberg |
KeyBanc | Paul Knight |
LBBW | Volker Stoll |
Metzler | Alexander Neuberger |
Morgan Stanley | Thibault Boutherin |
Morningstar | Max Jousma |
mwb Research | Harald Hof |
Nephron | Tom DeBourcy |
ODDO BHF | Oliver Metzger |
RBC Capital Markets | Charles Weston |
Redburn Atlantic | Ed Ridley-Day |
Stifel | Dylan Van Haaften |
UBS | Matthew Weston |
Wolfe Research | Doug Schenkel |
Disclaimer
Sartorius does not provide consensus data on its own website but redirects to Vara website.
Sartorius AG is covered by various German and international financial analysts, who provide their own research analyses and earnings estimates in respect of Sartorius AG. The most recent consensus is collected and provided by Vara Research and contains evaluations and estimates of these financial analysts. The consensus contains forward-looking statements, which are based on the current estimates and assumptions exclusively given by the participating analysts. Forward-looking statements are not to be understood as in any way guaranteeing that those expectations will turn out to be accurate. Future performance and the results achieved by Sartorius AG and its affiliated companies depend on a number of risks and uncertainties such as the future economic and market environment. Most of these factors are outside Sartorius’ control and cannot be accurately estimated in advance.
The consensus is not compiled by Sartorius, and Sartorius does not control, change or censor it. Therefore, Sartorius shall not be liable for any deviation between the consensus and the company’s financial results. The development of the consensus by Vara Research is independent and not influenced by Sartorius.
Sartorius solely provides links to Vara Research GmbH website, but it does not make any recommendations of its own. The publication of this information does not imply that Sartorius makes any representations, warranties, or accepts or confirms such information, conclusions, or recommendations. The company therefore assumes no responsibility for the accuracy or completeness of these estimates and does not undertake to supervise, update or revise them, or even to comment or correct them. This is a complete autonomous application of Vara Research and Sartorius assumes no action, nor bears any responsibility regarding the information contained.
Data published by Vara Research remains under the entire Vara Research responsibilities. By accessing these Vara Research’s data, you acknowledge that you have been made aware by Sartorius of the risks involved in using Vara Research’s data.
You, hereby agree to release Sartorius AG, its subsidiaries and affiliates, their directors, officers, and other representatives from any and all liabilities, whether directly or by way of indemnification, and you waive any and all claims for any direct and/or indirect, consequential damages, of any nature whatsoever (including in particular financial losses) arising directly or indirectly, from the access and use of Vara Research’s data and Vara Research’s website.
You are now leaving the Sartorius website to go to an independent third-party website.
By clicking the “I agree” button below, you will be transferred to a webpage which contains information that is maintained by Vara Research. The service presents consensus estimates and recommendations that are calculated and compiled regularly and independently by Vara Research. Sartorius has no control over the linked webpage and its content.
The consensus is collected and provided by Vara Research and can be found by clicking on the “I agree” button below.
By clicking to the “i agree” button below, you confirm your understanding of the above disclaimer and agree to all of its terms.
Shareholder Structure
Sartorius AG’s issued capital comprises 37,440,000 million ordinary shares and the same number of preference shares, each with a calculated par value of €1 per share. Some of both classes of share are held by the company itself. Minus these treasury shares, the number of ordinary shares outstanding is 34,230,928 and the number of preference shares outstanding is 34,807,268.
Sartorius AG Ordinary Shares (SRT)
in %, related to ~34.2 million shares outstanding
A good 55 % of the ordinary shares outstanding are under the management of an executor. According to the most recent information available, the U.S. company Bio-Rad Laboratories Inc. holds around 38 % of the ordinary shares outstanding. To our knowledge, the remaining approximately 7 % are in free float.
Information on shareholdings and shares in free float pursuant to the disclosure requirements of Sections 33 et seq. of the German Securities Trading Act (WpHG) and the shareholders’ own disclosures. These reporting obligations and own disclosures refer only to voting shares and not to non-voting preference shares. For this reason, the shareholder structure disclosed for Sartorius preference shares does not contain any detailed information beyond the company’s treasury shares.